Jamie Mullen

2.6k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Jamie Mullen is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Jamie Mullen has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 6 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Jamie Mullen's work include Schizophrenia research and treatment (12 papers), Bipolar Disorder and Treatment (11 papers) and Alzheimer's disease research and treatments (6 papers). Jamie Mullen is often cited by papers focused on Schizophrenia research and treatment (12 papers), Bipolar Disorder and Treatment (11 papers) and Alzheimer's disease research and treatments (6 papers). Jamie Mullen collaborates with scholars based in United States, United Kingdom and Spain. Jamie Mullen's co-authors include Björn Paulsson, Martin Brecher, Joseph R. Calabrese, Margaret Minkwitz, Robin McCoy, Terence A. Ketter, Richard H. Weisler, Andrew J. Cutler, Wayne Macfadden and Ellis Wilson and has published in prestigious journals such as American Journal of Psychiatry, Journal of Affective Disorders and Investigative Ophthalmology & Visual Science.

In The Last Decade

Jamie Mullen

21 papers receiving 1.6k citations

Hit Papers

A Randomized, Double-Blind, Placebo-Controlled Trial of Q... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
    2005 587 citations Joseph R. Calabrese, Paul E. Keck et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamie Mullen United States 14 1.4k 328 152 139 107 23 1.7k
Willie Earley United States 26 1.6k 1.1× 690 2.1× 113 0.7× 238 1.7× 63 0.6× 82 2.0k
Г. Ингенито United States 14 1.9k 1.3× 347 1.1× 234 1.5× 268 1.9× 192 1.8× 33 2.3k
Gustavo Alva United States 15 346 0.2× 233 0.7× 27 0.2× 37 0.3× 204 1.9× 37 957
Jack Hirschowitz United States 22 812 0.6× 164 0.5× 71 0.5× 144 1.0× 99 0.9× 63 1.4k
AF Cohen Netherlands 17 253 0.2× 294 0.9× 142 0.9× 55 0.4× 60 0.6× 31 1.0k
P Deniker France 17 435 0.3× 155 0.5× 54 0.4× 137 1.0× 41 0.4× 113 980
George E. Crane United Kingdom 19 661 0.5× 206 0.6× 83 0.5× 98 0.7× 64 0.6× 33 1.3k
Patrizia Cavazzoni United States 22 1.3k 0.9× 275 0.8× 86 0.6× 214 1.5× 299 2.8× 42 1.9k
John Cookson United Kingdom 19 772 0.5× 138 0.4× 253 1.7× 99 0.7× 48 0.4× 62 1.1k
Yuki Matsuda Japan 19 587 0.4× 242 0.7× 50 0.3× 117 0.8× 67 0.6× 77 1.2k

Countries citing papers authored by Jamie Mullen

Since Specialization
Citations

This map shows the geographic impact of Jamie Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Mullen more than expected).

Fields of papers citing papers by Jamie Mullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Mullen. The network helps show where Jamie Mullen may publish in the future.

Co-authorship network of co-authors of Jamie Mullen

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Mullen. A scholar is included among the top collaborators of Jamie Mullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Mullen. Jamie Mullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Jeremiah K. H., Qiao-Xin Li, Zheng He, et al.. (2020). Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease. Frontiers in Neuroscience. 14. 862–862. 42 indexed citations
2.
Stern, Robert A., Alette M. Wessels, Katherine J. Selzler, et al.. (2019). FTS3‐01‐03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT. Alzheimer s & Dementia. 15(7S_Part_17).
3.
Monk, Scott A., Alan R. Kugler, Scott W. Andersen, et al.. (2019). Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P‐gp Substrate. The Journal of Clinical Pharmacology. 60(5). 586–594. 3 indexed citations
4.
Tariot, Pierre N., Katherine J. Selzler, Alette M. Wessels, et al.. (2019). FTS3‐01‐02: SUBGROUP POPULATIONS IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT. Alzheimer s & Dementia. 15(7S_Part_17). 1 indexed citations
5.
Mullen, Jamie, et al.. (2018). Disulfiram en alcohol, een potentieel dodelijke cocktail. Tijdschrift voor Geneeskunde. 1398–1401. 1 indexed citations
6.
Sims, John R., AnnCatherine M. Downing, Scott W. Andersen, et al.. (2018). DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY. Alzheimer s & Dementia. 14(7S_Part_31).
7.
Monk, Scott A., Pankaj Daga, David M. Bender, et al.. (2018). Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics. Clinical Pharmacology in Drug Development. 7(3). 233–243. 12 indexed citations
8.
Lim, Jeremiah K. H., Qiao-Xin Li, Zheng He, et al.. (2016). The Eye As a Biomarker for Alzheimer's Disease. Frontiers in Neuroscience. 10. 136 indexed citations
9.
Martínez‐Arán, Anabel, Eduard Vieta, KN Roy Chengappa, et al.. (2008). Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change. Bipolar Disorders. 10(5). 566–579. 40 indexed citations
10.
Sajatovic, Martha, Joseph R. Calabrese, & Jamie Mullen. (2008). Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disorders. 10(6). 662–671. 38 indexed citations
11.
Sussman, Norman, Jamie Mullen, Björn Paulsson, & Mårten Vågerö. (2007). Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Journal of Affective Disorders. 100. S55–S63. 18 indexed citations
12.
Vieta, Eduard, Joseph F. Goldberg, Jamie Mullen, Mårten Vågerö, & Björn Paulsson. (2007). Quetiapine in the treatment of acute mania: Target dose for efficacious treatment. Journal of Affective Disorders. 100. S23–S31. 11 indexed citations
13.
Vieta, Eduard, Jamie Mullen, Martin Brecher, Björn Paulsson, & Martin Jones. (2005). Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Current Medical Research and Opinion. 21(6). 923–934. 89 indexed citations
14.
Calabrese, Joseph R., Paul E. Keck, Wayne Macfadden, et al.. (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression. American Journal of Psychiatry. 162(7). 1351–1360. 587 indexed citations breakdown →
15.
Bowden, Charles L., Heinz Grunze, Jamie Mullen, et al.. (2005). A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder. The Journal of Clinical Psychiatry. 66(1). 111–121. 254 indexed citations
16.
McIntyre, Roger S., Martin Brecher, Björn Paulsson, Karin Huizar, & Jamie Mullen. (2005). Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. European Neuropsychopharmacology. 15(5). 573–585. 160 indexed citations
17.
Yatham, Lakshmi N., et al.. (2004). Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania. Journal of Clinical Psychopharmacology. 24(6). 599–606. 130 indexed citations
18.
19.
20.
Eisenberg, Dan, et al.. (1996). Accuracy of Perkins applanation tonometry and pneumatonometry in infants and children. A manometric study in vitro. Investigative Ophthalmology & Visual Science. 37(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willie Earley Breakdown of academic impact, for papers by Г. Ингенито Breakdown of academic impact, for papers by Gustavo Alva Breakdown of academic impact, for papers by Jack Hirschowitz Breakdown of academic impact, for papers by AF Cohen Breakdown of academic impact, for papers by P Deniker Breakdown of academic impact, for papers by George E. Crane Breakdown of academic impact, for papers by Patrizia Cavazzoni Breakdown of academic impact, for papers by John Cookson Breakdown of academic impact, for papers by Yuki Matsuda
Rankless by CCL
2026